St. Anthony Foundation

PG&E Coworkers Celebrate Holiday Season Giving Back Through Volunteerism in Hometowns

Retrieved on: 
Monday, November 20, 2023

OAKLAND, Calif., Nov. 20, 2023 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) is kicking off the 2023 holiday season by partnering with nonprofit groups to give back to the customers and hometowns it is privileged to serve in Northern and Central California.

Key Points: 
  • As part of PG&E's annual holiday giving program called Campaign for our Hometowns, which began earlier this month, coworkers are volunteering with community organizations — from Eureka to Bakersfield — and giving to causes they care about.
  • PG&E volunteers will help bring joy to homebound senior neighbors this holiday season," said Marisa Melo, Executive Director, Meals on Wheels of Alameda County.
  • "We are eager to help in ways that are meaningful to our coworkers and will benefit the customers in our hometowns this holiday season, from volunteering at local food banks to assisting with holiday gift distributions.
  • Events where coworkers will volunteer in person include:
    Nov. 21: Giving Thanks on Golden Gate in support of St. Anthony's (San Francisco)

BioAge Appoints Rekha Hemrajani and Jason Coloma to its Board of Directors

Retrieved on: 
Thursday, August 19, 2021

BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of Rekha Hemrajani and Jason Coloma to the companys board of directors.

Key Points: 
  • BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of Rekha Hemrajani and Jason Coloma to the companys board of directors.
  • We are thrilled to welcome Jason Coloma and Rekha Hemrajani to BioAges board of directors, said Kristen Fortney, CEO of BioAge Labs.
  • Jason Coloma, MBA, Ph.D., is CEO of Maze Therapeutics, Inc. a biotech company focused on translating genetic insights into clinical innovations.
  • Rekha Hemrajani, MBA, is a senior executive with more than 20 years of biopharmaceutical industry experience.